#United States #Oakland #Koya Medical #Dayspring #Vascular Care

Koya Medical to Present at the Piper Sandler 36th Annual Healthcare Conference

Koya Medical, a prominent player in the medical device sector, is set to participate in the highly anticipated Piper Sandler 36th Annual Healthcare Conference. Scheduled for December 3, 2024, at 4:50 PM ET, Koya's CEO, Dr. Andy Doraiswamy, will provide crucial updates on the company's advancements in vascular care solutions.

Focus on Dayspring Treatment

One of the highlights of Koya Medical's presentation will be the discussion of Dayspring, an innovative integrative compression treatment designed for patients suffering from chronic edema related to venous and lymphatic disorders. This treatment addresses a pressing healthcare issue, as approximately 20 million Americans grapple with lymphedema, a debilitating condition that leads to painful swelling due to fluid accumulation in various body parts.

The recent findings from Koya's randomized multicenter trial, known as TEAYS, published in the Journal of Vascular Surgery, further solidify the efficacy of Dayspring. The trial demonstrated that Dayspring successfully met both primary and secondary endpoints, revealing a wide range of clinical benefits when compared to conventional methods of care.

Understanding Lymphedema and Venous Diseases

Lymphedema is a chronic condition that can arise from multiple factors, including chronic venous disease, cancer, infections, and surgical interventions. Patients often experience cumbersome lifelong maintenance treatments to manage swelling and pain, highlighting the critical need for effective therapies.

Koya Medical's Dayspring treatment is unique. It combines various compression techniques and encourages patient mobility, making it user-friendly and effective. The treatment has gained FDA clearance and is currently available in the United States, representing a significant advancement in the management of lymphedema and chronic edema.

Aiming for Better Patient Outcomes

Koya’s commitment to enhancing patient care through innovative solutions has never been more important. With a growing body of evidence supporting the effectiveness of Dayspring, Koya Medical stands at the forefront of developing treatments that promise to improve the quality of life for many suffering from chronic conditions.

The company aims to continue its research and development efforts, exploring new horizons in vascular care with a focus on patient-centered solutions. As they prepare for the Piper Sandler Healthcare Conference, the anticipation surrounding Koya Medical’s contributions to the field is palpable.

For more information and updates, visit Koya Medical's official website or follow them on their social media platforms.